 Sizhao Lu
Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepcidins | 5 | 2016 | 22 | 1.980 |
Why?
| | Atherosclerosis | 3 | 2023 | 404 | 0.850 |
Why?
| | Galectin 3 | 1 | 2022 | 21 | 0.750 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2019 | 450 | 0.750 |
Why?
| | Vascular Remodeling | 3 | 2022 | 196 | 0.730 |
Why?
| | PTEN Phosphohydrolase | 2 | 2020 | 163 | 0.720 |
Why?
| | Coronary Restenosis | 1 | 2019 | 21 | 0.610 |
Why?
| | Cyclin D1 | 1 | 2019 | 68 | 0.610 |
Why?
| | Vascular Diseases | 1 | 2019 | 244 | 0.520 |
Why?
| | Janus Kinases | 1 | 2016 | 15 | 0.480 |
Why?
| | ELAV-Like Protein 1 | 1 | 2015 | 16 | 0.470 |
Why?
| | Palmitic Acid | 1 | 2015 | 42 | 0.470 |
Why?
| | Glutathione Peroxidase | 1 | 2015 | 43 | 0.460 |
Why?
| | Ceramides | 1 | 2016 | 117 | 0.450 |
Why?
| | Catalase | 1 | 2015 | 134 | 0.450 |
Why?
| | STAT3 Transcription Factor | 2 | 2016 | 212 | 0.450 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2015 | 91 | 0.440 |
Why?
| | Trace Elements | 1 | 2015 | 51 | 0.440 |
Why?
| | Liver | 4 | 2023 | 1820 | 0.410 |
Why?
| | Hydrogen Peroxide | 1 | 2015 | 339 | 0.400 |
Why?
| | Fatty Liver | 1 | 2015 | 232 | 0.390 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2608 | 0.380 |
Why?
| | Fatty Acids | 1 | 2015 | 450 | 0.370 |
Why?
| | Mass Spectrometry | 1 | 2015 | 740 | 0.360 |
Why?
| | Ethanol | 2 | 2015 | 629 | 0.350 |
Why?
| | Transcription, Genetic | 2 | 2016 | 1487 | 0.320 |
Why?
| | Signal Transduction | 3 | 2016 | 5169 | 0.270 |
Why?
| | Myocytes, Smooth Muscle | 4 | 2022 | 260 | 0.270 |
Why?
| | Mice | 11 | 2023 | 18109 | 0.240 |
Why?
| | Hep G2 Cells | 2 | 2016 | 71 | 0.240 |
Why?
| | RNA, Messenger | 4 | 2016 | 2828 | 0.220 |
Why?
| | Fibrosis | 3 | 2023 | 542 | 0.210 |
Why?
| | Mice, Transgenic | 3 | 2019 | 2184 | 0.210 |
Why?
| | Azotemia | 1 | 2023 | 7 | 0.200 |
Why?
| | Iron | 2 | 2016 | 324 | 0.200 |
Why?
| | RNA, Small Interfering | 2 | 2016 | 627 | 0.200 |
Why?
| | Mice, Inbred C57BL | 6 | 2023 | 5909 | 0.190 |
Why?
| | Plaque, Atherosclerotic | 1 | 2023 | 58 | 0.190 |
Why?
| | Phosphorylation | 3 | 2016 | 1774 | 0.190 |
Why?
| | Hypercholesterolemia | 1 | 2023 | 101 | 0.190 |
Why?
| | Spinocerebellar Ataxias | 1 | 2022 | 6 | 0.190 |
Why?
| | Animals | 12 | 2023 | 37749 | 0.180 |
Why?
| | DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2020 | 16 | 0.160 |
Why?
| | Intestines | 1 | 2023 | 357 | 0.160 |
Why?
| | Cells, Cultured | 2 | 2019 | 4212 | 0.160 |
Why?
| | GATA4 Transcription Factor | 1 | 2019 | 19 | 0.150 |
Why?
| | Angiotensin II | 1 | 2019 | 99 | 0.150 |
Why?
| | Crohn Disease | 1 | 2023 | 254 | 0.150 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2019 | 37 | 0.150 |
Why?
| | Hyperplasia | 1 | 2019 | 176 | 0.150 |
Why?
| | High-Throughput Screening Assays | 1 | 2020 | 157 | 0.140 |
Why?
| | Promoter Regions, Genetic | 3 | 2020 | 1243 | 0.130 |
Why?
| | Blotting, Western | 1 | 2019 | 1234 | 0.130 |
Why?
| | Stem Cells | 2 | 2022 | 603 | 0.130 |
Why?
| | Adventitia | 1 | 2016 | 41 | 0.120 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2016 | 67 | 0.120 |
Why?
| | Dactinomycin | 1 | 2016 | 30 | 0.120 |
Why?
| | Anthracenes | 1 | 2016 | 32 | 0.120 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2016 | 136 | 0.120 |
Why?
| | Flow Cytometry | 1 | 2019 | 1197 | 0.120 |
Why?
| | Response Elements | 1 | 2016 | 90 | 0.120 |
Why?
| | Acute Kidney Injury | 1 | 2023 | 820 | 0.120 |
Why?
| | Transcription Factor CHOP | 1 | 2015 | 33 | 0.110 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2016 | 377 | 0.110 |
Why?
| | Disease Models, Animal | 3 | 2023 | 4421 | 0.110 |
Why?
| | 3' Untranslated Regions | 1 | 2015 | 149 | 0.110 |
Why?
| | Mutagenesis | 1 | 2015 | 182 | 0.110 |
Why?
| | Cytoplasm | 1 | 2015 | 273 | 0.110 |
Why?
| | Protein Kinase Inhibitors | 2 | 2023 | 919 | 0.110 |
Why?
| | Integrases | 1 | 2015 | 123 | 0.110 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 346 | 0.110 |
Why?
| | RNA Interference | 1 | 2016 | 469 | 0.110 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 1127 | 0.100 |
Why?
| | Protein Transport | 1 | 2015 | 448 | 0.100 |
Why?
| | Liver Diseases, Alcoholic | 1 | 2014 | 94 | 0.100 |
Why?
| | Protein Processing, Post-Translational | 1 | 2016 | 464 | 0.100 |
Why?
| | RNA | 1 | 2019 | 930 | 0.100 |
Why?
| | Recombinant Fusion Proteins | 1 | 2016 | 674 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 987 | 0.100 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2016 | 264 | 0.100 |
Why?
| | Toll-Like Receptor 4 | 1 | 2014 | 276 | 0.090 |
Why?
| | Mice, Inbred BALB C | 1 | 2015 | 1275 | 0.090 |
Why?
| | Cell Nucleus | 1 | 2015 | 609 | 0.090 |
Why?
| | NF-kappa B | 1 | 2016 | 692 | 0.090 |
Why?
| | Cell Proliferation | 1 | 2019 | 2506 | 0.090 |
Why?
| | Mutation | 3 | 2023 | 4015 | 0.090 |
Why?
| | Rats | 1 | 2019 | 5637 | 0.080 |
Why?
| | Lung Neoplasms | 1 | 2023 | 2567 | 0.080 |
Why?
| | Protein Binding | 1 | 2015 | 2242 | 0.070 |
Why?
| | Prevalence | 1 | 2016 | 2799 | 0.070 |
Why?
| | Humans | 5 | 2022 | 141754 | 0.070 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 3495 | 0.070 |
Why?
| | Male | 6 | 2023 | 70179 | 0.060 |
Why?
| | Corn Oil | 1 | 2023 | 5 | 0.050 |
Why?
| | Acute-Phase Reaction | 1 | 2023 | 39 | 0.050 |
Why?
| | Receptors, LDL | 1 | 2023 | 52 | 0.050 |
Why?
| | Furosemide | 1 | 2023 | 37 | 0.050 |
Why?
| | Proprotein Convertase 9 | 1 | 2023 | 87 | 0.050 |
Why?
| | Lipocalin-2 | 1 | 2023 | 79 | 0.050 |
Why?
| | Acrylamides | 1 | 2023 | 67 | 0.050 |
Why?
| | Obesity | 1 | 2016 | 3008 | 0.050 |
Why?
| | Neointima | 1 | 2022 | 15 | 0.050 |
Why?
| | Ileum | 1 | 2023 | 112 | 0.050 |
Why?
| | Aniline Compounds | 1 | 2023 | 120 | 0.050 |
Why?
| | Cell Differentiation | 2 | 2022 | 2006 | 0.050 |
Why?
| | Adaptive Immunity | 1 | 2023 | 173 | 0.040 |
Why?
| | Cholesterol | 1 | 2023 | 405 | 0.040 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2020 | 93 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2023 | 610 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2023 | 752 | 0.040 |
Why?
| | Pyrimidines | 1 | 2023 | 512 | 0.040 |
Why?
| | Azacitidine | 1 | 2020 | 150 | 0.040 |
Why?
| | Indoles | 1 | 2023 | 478 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2023 | 792 | 0.040 |
Why?
| | Homeostasis | 1 | 2022 | 636 | 0.030 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2023 | 833 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2022 | 816 | 0.030 |
Why?
| | Female | 3 | 2023 | 75943 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 2014 | 270 | 0.030 |
Why?
| | Transcription Factor RelA | 1 | 2014 | 85 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2014 | 309 | 0.030 |
Why?
| | Down-Regulation | 1 | 2014 | 641 | 0.020 |
Why?
| | Biomarkers | 1 | 2023 | 4190 | 0.020 |
Why?
| | Inflammation | 1 | 2023 | 2902 | 0.020 |
Why?
| | Binding Sites | 1 | 2014 | 1316 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2016 | 3071 | 0.020 |
Why?
| | Pregnancy | 1 | 2016 | 7092 | 0.010 |
Why?
|
|
Lu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|